BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 11494335)

  • 1. Polymorphic repeats in the androgen receptor gene in high-risk sibships.
    Miller EA; Stanford JL; Hsu L; Noonan E; Ostrander EA
    Prostate; 2001 Aug; 48(3):200-5. PubMed ID: 11494335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphic repeats in the androgen receptor gene: molecular markers of prostate cancer risk.
    Stanford JL; Just JJ; Gibbs M; Wicklund KG; Neal CL; Blumenstein BA; Ostrander EA
    Cancer Res; 1997 Mar; 57(6):1194-8. PubMed ID: 9067292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymorphic CAG and GGN repeat lengths in the androgen receptor gene and prostate cancer risk: a population-based case-control study in China.
    Hsing AW; Gao YT; Wu G; Wang X; Deng J; Chen YL; Sesterhenn IA; Mostofi FK; Benichou J; Chang C
    Cancer Res; 2000 Sep; 60(18):5111-6. PubMed ID: 11016637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How strong is the association between CAG and GGN repeat length polymorphisms in the androgen receptor gene and prostate cancer risk?
    Zeegers MP; Kiemeney LA; Nieder AM; Ostrer H
    Cancer Epidemiol Biomarkers Prev; 2004 Nov; 13(11 Pt 1):1765-71. PubMed ID: 15533905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The androgen receptor gene GGN microsatellite and prostate cancer risk.
    Platz EA; Giovannucci E; Dahl DM; Krithivas K; Hennekens CH; Brown M; Stampfer MJ; Kantoff PW
    Cancer Epidemiol Biomarkers Prev; 1998 May; 7(5):379-84. PubMed ID: 9610786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphic CAG/CAA repeat length in the AIB1/SRC-3 gene and prostate cancer risk: a population-based case-control study.
    Hsing AW; Chokkalingam AP; Gao YT; Wu G; Wang X; Deng J; Cheng J; Sesterhenn IA; Mostofi FK; Chiang T; Chen YL; Stanczyk FZ; Chang C
    Cancer Epidemiol Biomarkers Prev; 2002 Apr; 11(4):337-41. PubMed ID: 11927493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CAG repeat length in the androgen receptor gene is related to age at diagnosis of prostate cancer and response to endocrine therapy, but not to prostate cancer risk.
    Bratt O; Borg A; Kristoffersson U; Lundgren R; Zhang QX; Olsson H
    Br J Cancer; 1999 Oct; 81(4):672-6. PubMed ID: 10574254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymorphic CAG and GGC repeat lengths in the androgen receptor gene and prostate cancer risk: analysis of a Brazilian population.
    Silva Neto B; Koff WJ; Biolchi V; Brenner C; Biolo KD; Spritzer PM; Brum IS
    Cancer Invest; 2008 Feb; 26(1):74-80. PubMed ID: 18181049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The polymorphic exon 1 androgen receptor CAG repeat in men with a potential inherited predisposition to prostate cancer.
    Lange EM; Chen H; Brierley K; Livermore H; Wojno KJ; Langefeld CD; Lange K; Cooney KA
    Cancer Epidemiol Biomarkers Prev; 2000 Apr; 9(4):439-42. PubMed ID: 10794490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Androgen receptor polymorphisms and the incidence of prostate cancer.
    Chen C; Lamharzi N; Weiss NS; Etzioni R; Dightman DA; Barnett M; DiTommaso D; Goodman G
    Cancer Epidemiol Biomarkers Prev; 2002 Oct; 11(10 Pt 1):1033-40. PubMed ID: 12376504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Androgen receptor CAG polymorphism and prostate cancer risk.
    Mononen N; Ikonen T; Autio V; Rökman A; Matikainen MP; Tammela TL; Kallioniemi OP; Koivisto PA; Schleutker J
    Hum Genet; 2002 Aug; 111(2):166-71. PubMed ID: 12189490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sex steroid hormones and the androgen receptor gene CAG repeat and subsequent risk of prostate cancer in the prostate-specific antigen era.
    Platz EA; Leitzmann MF; Rifai N; Kantoff PW; Chen YC; Stampfer MJ; Willett WC; Giovannucci E
    Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1262-9. PubMed ID: 15894683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Difference between Swedish and Japanese men in the association between AR CAG repeats and prostate cancer suggesting a susceptibility-modifying locus overlapping the androgen receptor gene.
    Li C; Grönberg H; Matsuyama H; Weber G; Nordenskjöld M; Naito K; Bergh A; Bergerheim U; Damber JE; Larsson C; Ekman P
    Int J Mol Med; 2003 Apr; 11(4):529-33. PubMed ID: 12632109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased risk of breast cancer in women bearing a combination of large CAG and GGN repeats in the exon 1 of the androgen receptor gene.
    González A; Javier Dorta F; Rodriguez G; Brito B; Rodríguez MA; Cabrera A; Díaz-Chico JC; Reyes R; Aguirre-Jaime A; Nicolás Díaz-Chico B
    Eur J Cancer; 2007 Nov; 43(16):2373-80. PubMed ID: 17728127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The androgen receptor CAG repeat polymorphism and risk of breast cancer in the Nurses' Health Study.
    Haiman CA; Brown M; Hankinson SE; Spiegelman D; Colditz GA; Willett WC; Kantoff PW; Hunter DJ
    Cancer Res; 2002 Feb; 62(4):1045-9. PubMed ID: 11861380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Androgen receptor (CAG)n and (GGC)n polymorphisms and breast cancer risk in a population-based case-control study of young women.
    Suter NM; Malone KE; Daling JR; Doody DR; Ostrander EA
    Cancer Epidemiol Biomarkers Prev; 2003 Feb; 12(2):127-35. PubMed ID: 12582022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is reduced CAG repeat length in androgen receptor gene associated with risk of prostate cancer in Indian population?
    Mishra D; Thangaraj K; Mandhani A; Kumar A; Mittal R
    Clin Genet; 2005 Jul; 68(1):55-60. PubMed ID: 15952987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of short CAG and GGN repeats in the androgen receptor gene is associated with acne risk in North East China.
    Pang Y; He CD; Liu Y; Wang KB; Xiao T; Wang YK; Zhu H; Wei B; Zhao N; Jiang Y; Wei HC; Chen HD
    J Eur Acad Dermatol Venereol; 2008 Dec; 22(12):1445-51. PubMed ID: 18624843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Androgen, progesterone, and FSH receptor polymorphisms in ovarian cancer risk and outcome.
    Ludwig AH; Murawska M; Panek G; Timorek A; Kupryjanczyk J
    Endocr Relat Cancer; 2009 Sep; 16(3):1005-16. PubMed ID: 19458022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Androgen receptor gene CAG repeats, estrogen exposure status, and breast cancer susceptibility.
    Wu MH; Chou YC; Yu CP; Yang T; You SL; Chen CJ; Sun CA
    Eur J Cancer Prev; 2008 Aug; 17(4):317-22. PubMed ID: 18562955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.